Synlett 2017; 28(02): 231-234
DOI: 10.1055/s-0036-1588902
letter
© Georg Thieme Verlag Stuttgart · New York

Preparation of Spirocyclic β-Proline Esters: Geometrically Restricted Building Blocks for Medicinal Chemistry

Kasper Fjelbye
a   Discovery Chemistry & DMPK, H. Lundbeck A/S, Ottiliavej 9, 2500 Valby, Copenhagen, Denmark   Email: KAJU@Lundbeck.com
b   Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, 2 Universitetsparken, 2100 Copenhagen, Denmark
,
Mauro Marigo
a   Discovery Chemistry & DMPK, H. Lundbeck A/S, Ottiliavej 9, 2500 Valby, Copenhagen, Denmark   Email: KAJU@Lundbeck.com
,
Rasmus Prætorius Clausen
b   Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, 2 Universitetsparken, 2100 Copenhagen, Denmark
,
Karsten Juhl*
a   Discovery Chemistry & DMPK, H. Lundbeck A/S, Ottiliavej 9, 2500 Valby, Copenhagen, Denmark   Email: KAJU@Lundbeck.com
› Author Affiliations
Further Information

Publication History

Received: 17 August 2016

Accepted after revision: 05 October 2016

Publication Date:
17 October 2016 (online)


Abstract

A series of novel N-Bn-protected spirocyclic β-proline esters were prepared using [3+2] cycloaddition and subsequently converted into their corresponding aldehydes. In addition, two novel N-Cbz-protected spirocyclic β-proline esters were prepared using intramolecular cyclization starting from simple precursors.

Supporting Information

 
  • References and Notes

  • 1 Lamberth C, Dinges J. Bioactive Heterocyclic Compound Classes . Wiley-VCH; Weinheim: 2012: 1
    • 2a Kumar S, Thornton PD, Painter TO, Jain P, Downard J, Douglas JT, Santini C. J. Org. Chem. 2013; 78: 6529
    • 2b Zheng Y, Tice CM, Singh SB. Bioorg. Med Chem. Lett. 2014; 24: 3673
  • 3 Carreira EM, Fessard TC. Chem. Rev. 2014; 114: 8257
  • 4 Sannigrahi M. Tetrahedron 1999; 55: 9007
    • 5a Burkhard JA, Wuitschik G, Rogers-Evans M, Müller K, Carreira EM. Angew. Chem. Int. Ed. 2010; 49: 9052
    • 5b Wuitschik G, Rogers-Evans M, Müller K, Fischer H, Wagner B, Schuler F, Polonchuk L, Carreira EM. Angew. Chem. Int. Ed. 2006; 45: 7736
  • 6 Wuitschik G, Rogers-Evans M, Buckl A, Bernasconi M, Märki M, Godel T, Fischer H, Wagner B, Parrilla I, Schuler F, Schneider J, Alker A, Schweizer BW, Müller K, Carreira EM. Angew. Chem. Int. Ed. 2008; 47: 4512
    • 7a Grygorenko OO, Radchenko DS, Volochnyuk DM, Tolmachev AA, Komarov IV. Chem. Rev. 2011; 111: 5506
    • 7b Orain D, Hintermann S, Pudelko M, Carballa D, Jedrzejczak A. Synlett 2015; 26: 1815
    • 8a Srihari P, Yaragorla SR, Basu D, Chandrasekhar S. Synthesis 2006; 2646
    • 8b Stachel SJ, Steele TG, Petrocchi A, Haugabook SJ, McGaughey G, Holloway MK, Allison T, Munshi S, Zuck P, Colussi D, Tugasheva K, Wolfe A, Graham SL, Vacca JP. Bioorg. Med. Chem. Lett. 2012; 22: 240
  • 9 Compound 1e is mentioned in a Japanese patent application: Yoshida K, Ochiai H, Tani K, Shibayama S, Kasano M. WO 2010147094, 2010
  • 10 Suresh S, Periasamy M. Tetrahedron Lett. 2004; 45: 6291
  • 11 Meyer SD, Schreiber SL. J. Org. Chem. 1994; 59: 7549
  • 12 General Procedure for the Synthesis of β-Proline Esters Using Cycloaddition To a stirred solution of an unsaturated ester (1 equiv) in toluene (0.4 M w.r.t. the ester) was added N-benzyl-1-methoxy-N-[(trimethylsilyl)methyl]methanamine (1.5 equiv) at 0 °C under argon. After 10 min, a solution of TFA (0.1 equiv) in CH2Cl2 (1 M w.r.t. TFA) was added to the mixture, and stirring was continued for 2–18 h while allowing the temperature to slowly reach r.t. Subsequently, the volatiles were removed in vacuo, and the resulting crude residue was purified using silica gel chromatography to provide the desired cycloaddition product 1ae. Ethyl 6-Benzyl-2-oxa-6-azaspiro[3.4]octane-8-carboxylate (1a) The general procedure A over 12 h provided 1a (5.3 g, 19.25 mmol, 55% yield) as a colorless oil. 1H NMR (600 MHz, CDCl3): δ = 7.33–7.29 (m, 4 H), 7.27–7.24 (m, 1 H), 4.72–4.64 (m, 2 H), 4.51–4.43 (m, 2 H), 4.23–4.15 (m, 2 H), 3.66–3.60 (m, 2 H), 3.21 (d, J = 9.2 Hz, 1 H), 3.10–3.02 (m, 2 H), 2.74 (dd, J = 9.3, 0.8 Hz, 1 H), 2.62–2.59 (m, 1 H), 1.30 (t, J = 7.2 Hz, 3 H). 13C NMR (151 MHz, CDCl3): δ = 173.0, 138.5, 128.6, 128.3, 127.1, 84.0, 77.9, 64.3, 60.9, 59.6, 56.5, 50.4, 47.9, 14.3. ESI-HRMS: m/z calcd for C16H22NO3 [MH+]: 276.1594; found: 276.1599.